Glioblastoma (GBM), an aggressive brain cancer, is notoriously resistant to treatment, with recurrent GBM associated with survival of less than 10 months. Immunotherapies, which mobilize the… Read More
An anonymous reader quotes a report from the Financial Times: A world-first trial of a gene therapy to cure a form of deafness has begun, potentially heralding a revolution in the treatment… Read More
Key drivers of the stem cell therapy market include increase in stem cell research funding, expanding number of clinical trials related to stem cell therapies, and growing number of GMP-cert… Read More
HIV (human immunodeficiency virus) is a devastating global health crisis that has affected millions of individuals worldwide; in 2022 alone, nearly 39 million individuals were living with th… Read More
Biotech is a hot sector. It’s on the cutting edge of science and technology and that always attracts investor attention. But what is biotech, really, and what are the best biotech stoc… Read More
MADRID — First-line treatment with the RET inhibitor selpercatinib (Retevmo) achieved superior outcomes in both medullary thyroid cancer (MTC) and advanced non-small cell lung canc… Read More
Clinical research is a vital aspect of healthcare that aims to study the safety and efficacy of medical interventions using various types of clinical trials, which are conducted in different… Read More
(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Neuroendocrine Tumors pipeline constitutes 55+ key companies continuously working towards developing 60… Read More
(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Glioblastoma pipeline constitutes 195+ key companies continuously working towards developing 210+ Gliob… Read More
Retinitis Pigmentosa News 2023 is here, and it’s important to understand the implications of this Retinitis Pigmentosa News 2023. Retinitis Pigmentosa is a degenerative eye condition t… Read More
[Sept. 30, 2023: Staff Writer, The Brighter Side of News] The work serves as a foundational guide for physicians and scientists to understand disease development and improve treatment outco… Read More
Company to Provide Updates on Phase 2 Clinical Trials
for Next Generation COVID-19 Vaccine and Cancer Immunotherapy Programs
ATLANTA, GA – (NewMediaWire) –… Read More
Many parents would say that having a child with Attention Deficit Hyperactivity Disorder (ADHD) is like living in a wild world. An ADHD child's brain always bustles with thoughts and impulse… Read More
Preclinical Data for GEO-CM02 Demonstrates Single-Dose Protection
Against Multiple SARS-CoV-2 Variants
ATLANTA, GA – (NewMediaWire) – September 20, 2023 – GeoVax L… Read More